Jury Awards $52 Million in Damages to Promega Corporation
Published: Feb 16, 2012
In November 2011 the Court’s ruling on Summary Judgment confirmed the validity of Promega Short Tandem Repeat (STR) patents, and found direct infringement by Life Technologies due to their sale of STR kits.
“The Court’s ruling and the jury award confirm the value of Promega STR technology and its contributions to genetic analysis in the fields of research and molecular diagnostics,” says Bill Linton, Promega CEO.
Promega’s pioneering STR technology is used worldwide in a number of applications for genetic analysis beyond forensics and paternity testing, including genetic research, cell line authentication, bone marrow transplantation monitoring, forensic training, and various types of cancer analysis.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.
Penny Patterson, (608) 274-4330
Director, Corporate Affairs